Clinical Risk Management for Emerging Companies

Even before the pandemic, smaller companies often did not have the budget to travel or attend conferences. When they do attend conferences, the feedback is often that the content is not scalable for limited resources and therefore not applicable for their working environment. There is a demand for a conference developed specifically for these companies and executed in a more hands-on learning format to teach them what they don’t know.

At emerging companies there is often only one person responsible for EVERYTHING clinical. Their focus is on pushing their product through the early stages of clinical trials and they are not familiar with the ins and outs of clinical quality to know what is and isn’t required or needed to achieve GCP inspection readiness.

When emerging companies are acquired, or they grow to a size where a spotlight must be shone on the clinical quality and compliance processes, this is when the inefficiencies of their CQRM system or lack there of, these start-up mistakes are uncovered and the system rebuilt from the ground up, requiring many resources that often are not available.

For this conference we have to go back to basics and the building blocks of an effective clinical quality foundation, breaking down the critical components to the bare minimum. The format will be geared towards more tactile learning with workshops on day one and then during the two days of the main conference a session format instructional, followed by a panel of real-life experiences.